Offering individual, couples, and group therapy, ketamine-assisted therapy, medication management…
Offering individual, couples, and group therapy, ketamine-assisted therapy, medication management…

Rehabilitation of Neuropsychiatric Symptoms in Patients With Long COVID

From Amanda Sacks-Zimmerman et al, biopsychosocial framework for long COVID and treatment strategies based on evidence from current literature of postviral chronic illness.
neurons

Table of Contents

Abstract

Long COVID, a term used to describe ongoing symptoms after COVID-19 infection, parallels the course of other postviral syndromes. Neuropsychiatric symptoms of long COVID can be persistent and interfere with quality of life and functioning. Within the biopsychosocial framework of chronic illness, rehabilitation professionals can address the neuropsychiatric sequelae of long COVID. However, current practice models are not designed to address concurrent psychiatric and cognitive symptoms in adults living with long COVID. Thus, we present a biopsychosocial framework for long COVID and provide treatment strategies based on evidence from current literature of postviral chronic illness. These recommendations will guide rehabilitation professionals in identifying common neuropsychiatric symptoms in long COVID that can be targeted for intervention and addressing these symptoms via integrative interventions taking into account the biopsychosocial presentation of long COVID symptoms.

Keywords: Cognitive Behavioral Therapy; Cognitive Rehabilitation; Cognitive Remediation; Fatigue; Long COVID; Pain; Position Statement; Rehabilitation.

About This Paper:

Sacks-Zimmerman A, Bergquist TF, Farr EM, Cornwell MA, Kanellopoulos D. “Rehabilitation of Neuropsychiatric Symptoms in Patients With Long COVID: Position Statement.” Arch Phys Med Rehabil. 2023 Feb;104(2):350-354. doi: 10.1016/j.apmr.2022.10.001. Epub 2022 Oct 20. PMID: 36272444; PMCID: PMC9581644. Visit on PubMed

 

About the Author

Amanda Sacks-Zimmermann PhD

Amanda Sacks-Zimmerman, PhD, ABPP

Amanda Sacks-Zimmerman, PhD, ABPP, is clinical director of Acheron Psychiatry, where she specializes in neurocognitive care, as well as Clinical Associate Professor of Neuropsychology in Neurological Surgery at Weill Cornell Medicine.

Ask a Question

About Acheron Psychiatry

Acheron is a psychiatrist-led, multi-therapist practice offering individual, couples, and group therapy, including ketamine-assisted psychotherapy. Under the supervision of Harvard-trained psychiatrist Daniel Zimmerman, M.D., your ketamine-assisted treatment at Acheron is a healing experience for mind, body, and soul. Contact us now for a free consultation.

Ketamine-Assisted Psychotherapy (KAP)

Ketamine-assisted therapy is an advanced treatment that has been shown to be effective for certain mental health issues, especially when other treatments have not succeeded. The psychiatrist-led Acheron team has expertise in this unique medical therapy.

Find out more about medically supervised ketamine-assisted psychotherapy.

Follow Us for Blog Updates

Reach Out Today

You can use this form to ask us anything or to schedule a complimentary phone consultation.